We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Clinical Dentistry

Journal Scan / Review · March 09, 2021

Tumor-Derived Exosomes (TEX) From Oral Squamous Cell Carcinoma Can Serve as Early Biomarkers of the Disease

Journal of Oral Pathology & Medicine


Additional Info

Journal of Oral Pathology & Medicine
Assessing the Analytical Efficacy of TEX in Diagnosing Oral Cancer Using a Systematic Review Approach
J. Oral Pathol. Med. 2021 Feb 01;50(2)123-128, S Sahu, S Routray

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading